Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

May 4, 2011

30339_dirs_2011-05-04_28354100-9fb1-4ee8-9ef9-8694ce0b6771.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-05-04

Reporting Person: GAILEY JOHN R (VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-04 Common Stock M 14600.0000 $19.3650 Acquired 37701.9673 Direct
2011-05-04 Common Stock S 14600.0000 $46.9202 Disposed 23101.9673 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-04 Stock Option (Right to Buy) $19.3650 M 14600.0000 Disposed 2015-05-05 Common Stock (14600.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 702.3053 Indirect
Common Stock 9685.1447 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.